Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials

Evaluation of the Pharmacokinetics of IPX237 Formulations in Healthy Volunteers

To see complete record on, please visit this link

Id: ACTRN12613001097730

Organisation Name: Impax Pharmaceuticals, A Division of Impax Laboratories, Inc.

Overal Status: Completed

Start Date: 09/12/2013

Brief Summary: To characterize the pharmacokinetics (PK) of esketamine hydrochloride from 2 oral and 1 sublingual formulations of IPX237 compared to that from intravenous esketamine hydrochloride.

  • Australia
  • United States of America

Total execution time in seconds: 0.15349698066711